Duke University Trials Lattice Radiation Therapy for Large Tumors
Duke University is investigating Lattice Radiation Therapy (LRT) in combination with palliative radiation for large tumors.
Phase III
Oncology / Radiation Therapy
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The investigation of Lattice Radiation Therapy (LRT) by Duke University could significantly alter treatment protocols for large tumors in oncology. If successful, LRT may provide a competitive edge in radiation therapy, necessitating strategic adjustments by pharma companies involved in oncology.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results regarding safety and efficacy of LRT compared to standard radiation therapy over the next year.
Related companies & assets
Sources & Humanexa intelligence
Related Humanexa pages
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.